JP2005522210A5 - - Google Patents

Download PDF

Info

Publication number
JP2005522210A5
JP2005522210A5 JP2003583334A JP2003583334A JP2005522210A5 JP 2005522210 A5 JP2005522210 A5 JP 2005522210A5 JP 2003583334 A JP2003583334 A JP 2003583334A JP 2003583334 A JP2003583334 A JP 2003583334A JP 2005522210 A5 JP2005522210 A5 JP 2005522210A5
Authority
JP
Japan
Prior art keywords
polypeptide
fusion protein
biological sample
antigen
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003583334A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005522210A (ja
Filing date
Publication date
Priority claimed from US10/121,988 external-priority patent/US20030068327A1/en
Priority claimed from US10/200,562 external-priority patent/US20030165819A1/en
Priority claimed from US10/237,551 external-priority patent/US6821519B2/en
Application filed filed Critical
Publication of JP2005522210A publication Critical patent/JP2005522210A/ja
Publication of JP2005522210A5 publication Critical patent/JP2005522210A5/ja
Withdrawn legal-status Critical Current

Links

JP2003583334A 2002-04-11 2003-04-09 単純ヘルペスウイルス感染の診断および処置に対する組成物および方法 Withdrawn JP2005522210A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/121,988 US20030068327A1 (en) 2000-06-29 2002-04-11 Compositions and methods for the diagnosis and threatment of herpes simplex virus infection
US10/200,562 US20030165819A1 (en) 2000-06-29 2002-07-19 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
US10/237,551 US6821519B2 (en) 2000-06-29 2002-09-06 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
PCT/US2003/011231 WO2003086308A2 (en) 2002-04-11 2003-04-09 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection

Publications (2)

Publication Number Publication Date
JP2005522210A JP2005522210A (ja) 2005-07-28
JP2005522210A5 true JP2005522210A5 (https=) 2006-06-29

Family

ID=29255203

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003583334A Withdrawn JP2005522210A (ja) 2002-04-11 2003-04-09 単純ヘルペスウイルス感染の診断および処置に対する組成物および方法

Country Status (6)

Country Link
US (1) US6821519B2 (https=)
EP (1) EP1492563A4 (https=)
JP (1) JP2005522210A (https=)
AU (1) AU2003221897A1 (https=)
CA (1) CA2481087A1 (https=)
WO (1) WO2003086308A2 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2272859T3 (en) * 1998-08-07 2015-01-19 Univ Washington Immunological herpes simplex virus antigens and methods for their use
US6507042B1 (en) * 1998-12-25 2003-01-14 Fujitsu Limited Semiconductor device and method of manufacturing the same
US20040170642A1 (en) * 2000-08-17 2004-09-02 Jorg Fritiz Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof
JP4519461B2 (ja) * 2001-07-31 2010-08-04 ユニヴァーシティ オブ ワシントン 免疫学的に重要な単純ヘルペスウイルス抗原およびそれを用いる方法
DK1523582T3 (da) * 2002-07-18 2009-03-02 Univ Washington Hurtig, effektiv rensning af HSV-specifikke T-lymfocytter samt HSV-antigener identificeret derved
US7267940B2 (en) * 2003-03-04 2007-09-11 Bio-Rad Laboratories, Inc. HSV-2 type-specific immunoassays using glycoprotein G2 peptides
US20040203084A1 (en) * 2003-04-10 2004-10-14 Doug Levinson Profiling conformational variants, antibody compositions and methods of using the same
CA2523016C (en) * 2003-04-25 2018-05-15 Becton, Dickinson And Company Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
JP2007505147A (ja) * 2003-09-12 2007-03-08 アンティジェニクス インコーポレーテッド 単純ヘルペスウイルス感染の治療および予防用ワクチン
US7638318B2 (en) * 2003-09-26 2009-12-29 Norvartis Ag Seneca Valley virus based compositions and methods for treating disease
CN101023187A (zh) * 2004-03-05 2007-08-22 伯乐实验室有限公司 使用糖蛋白g2肽的hsv-2型特异性免疫测试
EP1913141A2 (en) * 2005-06-03 2008-04-23 The CBR Institute for Biomedical Research, Inc. Sirna microbicides for preventing and treating viral diseases
US7763460B2 (en) 2005-06-24 2010-07-27 Focus Diagnostics, Inc. Methods and compositions for detecting herpes simplex virus type 2
EP2521786B1 (en) 2006-07-20 2015-06-24 Vical Incorporated Compositions for vaccinating against hsv-2
US8865185B2 (en) 2006-09-08 2014-10-21 The Trustees Of The University Of Pennsylvania Methods of use for HSV-1 and HSV-2 vaccines
JP5639361B2 (ja) 2006-09-08 2014-12-10 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア Hsv−1及びhsv−2ワクチン並びにその使用方法
WO2008085486A1 (en) 2006-12-28 2008-07-17 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US20130028925A1 (en) * 2006-12-28 2013-01-31 Harvey Friedman Herpes simplex virus combined subunit vaccines and methods of use thereof
US10478490B2 (en) 2006-12-28 2019-11-19 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US8460674B2 (en) 2009-02-07 2013-06-11 University Of Washington HSV-1 epitopes and methods for using same
WO2010115172A2 (en) 2009-04-03 2010-10-07 University Of Washington Antigenic peptide of hsv-2 and methods for using same
EP3756684A1 (en) * 2009-05-22 2020-12-30 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
EP2643014A4 (en) * 2010-11-24 2015-11-11 Genocea Biosciences Inc HERPES SIMPLEX TYPE 2 VIRUS VACCINES: COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE
US9629906B2 (en) 2011-10-05 2017-04-25 Genvec, Inc. Affenadenovirus (gorilla) or adenoviral vectors and methods of use
EP2764012B1 (en) 2011-10-05 2022-02-23 GenVec, Inc. Adenoviral vectors and methods of use
WO2013052832A2 (en) 2011-10-05 2013-04-11 Genvec, Inc. Adenoviral vectors and methods of use
EP2782597B1 (en) * 2011-11-23 2022-04-13 Genocea Biosciences, Inc. Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
KR102136433B1 (ko) 2012-05-16 2020-07-22 이뮨 디자인 코포레이션 Hsv-2 백신
EP2855511B1 (en) 2012-05-29 2019-07-24 GenVec, Inc. Herpes simplex virus vaccine
JP2019537555A (ja) 2016-09-28 2019-12-26 ジェノセア バイオサイエンシーズ, インコーポレイテッド ヘルペスを処置するための方法および組成物
KR101962683B1 (ko) * 2016-09-28 2019-03-27 주식회사 에스엘백시젠 Hsv-2 감염 예방 및 치료용 dna 백신
WO2018186755A1 (en) * 2017-04-04 2018-10-11 Beagley Kenneth Novel vaccine for the prevention or treatment of an infection caused by a herpes virus.
CN109701008B (zh) * 2019-02-18 2022-06-21 山东兴瑞生物科技有限公司 针对单纯疱疹病毒的治疗性dc复合疫苗及其制备方法
EP3999093A4 (en) * 2019-07-19 2023-11-22 Merck Sharp & Dohme LLC ANTIGENIC E GLYCOPROTEIN POLYPEPTIDES, COMPOSITIONS AND METHODS OF USE THEREOF
KR20220035457A (ko) * 2019-07-21 2022-03-22 글락소스미스클라인 바이오로지칼즈 에스.에이. 치료 바이러스 백신
WO2025153100A1 (en) * 2024-01-19 2025-07-24 Sichuan Clover Biopharmaceuticals, Inc. Herpes simplex virus recombinant antigen and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW232710B (https=) 1991-09-13 1994-10-21 American Cyanamid Co
ATE157882T1 (de) * 1993-03-23 1997-09-15 Smithkline Beecham Biolog 3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
US6197497B1 (en) * 1995-04-21 2001-03-06 University Of New Mexico Immunoassay for herpes simplex virus
AT404838B (de) 1995-11-24 1999-03-25 Immuno Ag Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
CA2270282A1 (en) * 1996-11-04 1998-05-14 Smithkline Beecham Corporation Novel coding sequences from herpes simplex virus type-2
US6022847A (en) * 1997-03-19 2000-02-08 Zymogenetics, Inc. Secreted salivary zsig32 polypeptides
CA2291010A1 (en) 1997-06-02 1998-12-10 Chiron Corporation Herpes simplex virus vp22 vaccines and methods of use
WO1999064633A1 (en) 1998-06-10 1999-12-16 Smithkline Beecham Corporation Herpes simplex virus origin binding protein n-terminal truncation (obp-nt)
DK2272859T3 (en) 1998-08-07 2015-01-19 Univ Washington Immunological herpes simplex virus antigens and methods for their use
HK1044799A1 (zh) 1999-09-30 2002-11-01 University Of Washington 免疫学上重要的单纯疱疹病毒抗原

Similar Documents

Publication Publication Date Title
JP2005522210A5 (https=)
FI106317B (fi) Hepatiitti-C-viruksen (HCV) antigeeniyhdistelmät käytettäväksi anti-HCV-vasta-aineiden immunomäärityksissä
ES2650395T3 (es) Kits de diagnóstico y métodos de inmunoensayo para el diagnóstico y la diferenciación de virus de la fiebre porcina africana (ASFV) y virus de la fiebre porcina clásica (CSFV)
JPS6180048A (ja) 重抗原のための螢光偏光イムノアツセイ
JP2005504513A5 (https=)
Roggendorf et al. Comparison of solid phase test systems for demonstrating antibodies against hepatitis A virus (anti‐HAV) of the IgM‐class
JPS63225398A (ja) エプスタイン・バーウイルス初期抗原(拡散)に関連する合成ポリペプチドおよび抗体
US5645983A (en) Core antigen protein of hepatitis C virus, and diagnostic method and kit using the same
CN104246504A (zh) A型流感病毒的检测试剂盒
JP2001505778A (ja) HIV感染の初期の検出のための未変性の(non―dentured)HIV抗原を使用する新規のEIA試験
CN101165491B (zh) 以金磁微粒为载体检测抗双链dna抗体的方法
Bolognesi et al. Immunological properties of avian oncornavirus polypeptides
CN115176162B (zh) 新型冠状病毒抗原及其检测用途
JPS62249999A (ja) 非a非b型ウイルス性肝炎検出用試薬および免疫酵素法による前記肝炎の診断法
US20130337434A1 (en) Method of Preparing Magnetic Bead Type Nasopharyngeal Enzyme Immunoassay Reagents by Polymerase Chain Reaction
CN110996986B (zh) Hcv抗原的多表位融合蛋白及其用途
CN108948153B (zh) 一种瓜氨酸修饰肽抗原组合及其应用
WO2009137559A1 (en) Method for detecting a virus
WO2003040186A1 (en) Monoclonal antibody against canine distemper virus and method of diagnosis of distemper
JPH0940694A (ja) 肝炎gbウイルスの合成ペプチド及びその使用
CN108948173B (zh) 一种瓜氨酸修饰肽及其应用
Sánchez-Vizcaíno African swine fever diagnosis
CN101781360B (zh) 一种重组风疹病毒蛋白及应用
ES2257095T3 (es) Especificidad mejorada en la deteccion de anticuerpos igm de anti-rubeola.
JP3274743B2 (ja) 診断用キット